有投资者向济川药业提问, 咱们那个儿童增长药,大概什么时候能够上市?或者估计什么时候能够上市?公司回答表示,尊敬的投资者,您好。公司与天境生物合作的伊坦生长激素上市申请已于2024年12月获药品评价中心受理。如有重大进展或变化,公司也将严格按照相关法律法规要求,及时履行信息披露义务。感谢您的关注!
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.